Respiri Share Price and Company Fundamentals
Last traded: Last Friday at 1:36 AM
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and Israel. The company develops, produces, and sells mobile health applications. Its products include Wheezo, an asthma management tool to help user understand their asthma by providing information, such as triggers, symptoms, medication usage, and other events. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
|Primary activities||e-Health SaaS company supporting respiratory health management.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||432 St Kilda Road Suite 1 Level 9 Melbourne VIC 3004 Australia|
|Phone / Fax||61 1300 11 7377 / 61 3 9822 7735|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Respiri does not pay dividends.
As of Sep 2021, following are the company executives and directors listed on Respiri.
|Mr. Nicholas Smedley||Exec. Chairman||203.64k|
|Mr. Marjan Mikel B.Sc., M.A.I.C.D.||CEO, MD & Exec. Director||450k|
|Mr. Peter Hildebrandt||Chief Operationg Officer||249.88k|
|Dr. Samaneh Sarraf Shirazi||Chief Research Officer||183.37k|
|Mr. Theo Antonopoulos||Chief Commercial Officer||276.74k|
|Mr. Philippe Ludekens||Gen. Mang. of Commercial Operations||259.87k|
|Ms. Jan P. Barker||Vice-Pres of Bus. Devel.|
|Mr. Alastair Beard||Company Sec.|
|Prof. Noam Gavriely||Medical & Scientific Advisor|
|Mr. Simon Godfrey||Medical & Scientific Advisor|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Respiri is 54.94M and its enterprise value is 47.07M. The enterprise value to revenue ratio of RSH is 33.96.
Companies similar to Respiri (RSH)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Respiri (ASX:RSH) Frequently Asked Questions
1. What is Respiri's Stock Symbol?
Respiri trades on ASX under the ticker symbol "RSH".
2. What is Respiri's stock price today?
One share of RSH stock can currently be purchased for approximately $0.076.
3. How can I contact Respiri?
Respiri's mailing address is 432 St Kilda Road Suite 1 Level 9 Melbourne VIC 3004 Australia. The company can be reached via phone at 61 1300 11 7377.
4. What is Respiri's official website?
The official website of Respiri is http://respiri.co.
5. Which share registry manages Respiri's stock?
Respiri's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.